Concepedia
Statistics
Publications
18
Citations
714
H-Index
16
Active since
2012
Affiliations
The University of Tokyo(Current)
National Center for Global Health and Medicine
Yokohama Welfare Service Association
University of California, San Francisco
Saitama Medical University
Aki Miyasaka is an author at The University of Tokyo specializing in medicine, oncology, and molecular oncology.
Publications per year
2012–2019
Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas
Keiko Shoji, Katsutoshi Oda, Tomoko Kashiyama et al. · PLoS ONE · 2012 · 82 citations · Full text
Medicine, Oncology, Pharmacology +17
The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition
Tomohiko Fukuda, Katsutoshi Oda, Osamu Wada‐Hiraike et al. · Gynecologic Oncology · 2015 · 79 citations
Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
Shinya Oki, Kenbun Sone, Katsutoshi Oda et al. · Oncotarget · 2017 · 67 citations · Full text
Medicine, Genetics, Oncology +17
Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
Aki Miyasaka, Katsutoshi Oda, Yuji Ikeda et al. · BMC Cancer · 2014 · 63 citations · Full text
Medicine, Oncology, Pharmacology +15
PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer
Aki Miyasaka, Katsutoshi Oda, Yuji Ikeda et al. · Gynecologic Oncology · 2015 · 56 citations
Medicine, Cancer Biology, Oncology +15
1–5 of 18